Author

G. A. Fishbein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Cell Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell-cell communication· 1

Frequent Co-Authors

E. Fung· 2 shared A. E. Prosper· 1 shared A. Gower· 1 shared A. Petcherski· 1 shared A. Purkayastha· 1 shared A. Spira· 1 shared B. Gomperts· 1 shared B. J. Dillon· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

E. Fung

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Spatial Multi-omics of Arterial Regions from Cardiac Allograft Vasculopathy Rejected Grafts

J. Nevarez-Mejia, H. C. Pickering, R. A. Sosa, G. A. Fishbein, W. M. Baldwin, R. L. Fairchild, E. F. Reed

This study identifies protein and transcriptomic signatures distinguishing early and late stages of cardiac allograft vasculopathy using spatial multi-omics analysis of rejected grafts.

bioRxiv · Apr 12, 2023 · PreprintImmunology

COP9 Signalosome Promotes Neointimal Hyperplasia via Deneddylation and CSN5-Mediated Nuclear Export

S. Giri, C. Suo, R. Pardi, G. A. Fishbein, K. Rezvani, Y. Chen, X. Wang

This study shows that the COP9 signalosome promotes neointimal hyperplasia via deneddylation and CSN5-mediated nuclear export of p27 in vascular smooth muscle cells.

bioRxiv · Apr 11, 2023Cell Biology

Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models

A. Petcherski, M. Sharma, S. Satta, M. Daskou, H. Vasilopoulos, C. Hugo, E. Ritou, B. J. Dillon, E. Fung, G. Garcia, C. Scafoglio, A. Purkayastha, B. Gomperts, G. A. Fishbein, V. Arumugaswami, , T. Kelesidis

Mitoquinone mesylate shows antiviral and anti-inflammatory effects against SARS-CoV-2 in preclinical models.

bioRxiv · Feb 22, 2022 · PreprintMicrobiology

Single-cell characterization of subsolid and solid lesions in the lung adenocarcinoma spectrum

J. Yanagawa, L. M. Tran, E. Fung, W. D. Wallace, A. E. Prosper, G. A. Fishbein, C. Shea, R. Hong, B. Liu, R. Salehi-Rad, J. Z. Deng, A. Gower, J. D. Campbell, S. A. Mazzilli, J. Beane, , S. M. Dubinett

The paper uses single-cell RNA sequencing to compare immune and non-immune cell features in subsolid, solid, and non-involved lung tissues, finding reduced cytolytic activity and increased regulatory T cells in subsolid lesions.

bioRxiv · Dec 25, 2020 · PreprintCancer Biology

An Antioxidant Enzyme Therapeutic for COVID-19

M. Qin, Z. Cao, J. Wen, Q. Yu, C. Liu, F. Wang, F. Yang, Y. Li, G. A. Fishbein, S. Yan, B. Xu, Y. Hou, Z. Ning, K. Nie, N. Jiang, , Y. Lu

This paper describes a catalase-based therapeutic for COVID-19 that reduces oxidative stress and cytokine production in human and animal models without toxicity.

bioRxiv · Jul 15, 2020Biochemistry